| ²é¿´: 2901 | »Ø¸´: 60 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û48´Î£¬×÷ÕßruninwindÔö¼Ó½ð±Ò 43.25 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
·ÖÏí¿¹Ö×ÁöÒ©ÎïºÃÊéÒ»±¾<Cancer Drug Design and Discovery>2008¡¾ËÑËØÎÞÖØ¸´¡¿
|
||
|
Stephen Neidle is Professor of Chemical Biology, CRUK Professorial Fellow, and Director of the Centre for Cancer Medicines at the School of Pharmacy, University of London, where he directs a group working on the structure-based design and medicinal chemistry of novel agents targeting telomerase and other cancer-related genes. His work has been recognized by the Medicinal Chemistry and Interdisciplinary Awards of the Royal Society of Chemistry, and the Aventis Award of the French Societ¨¦ de Chimie Th¨¦rapeutique. ¸Õ´ÓSDÉÏÏÂÔØµÄ£¬Óë´ó¼Ò·ÖÏí http://d.namipan.com/d/77342c456aeb1ebcf10b6aff32d0799dffeb91ffa7517f00 |
» ²ÂÄãϲ»¶
291Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
309Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
085601²ÄÁϹ¤³ÌÕÒµ÷¼Á
ÒѾÓÐ10È˻ظ´
297Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ6È˻ظ´
070305¸ß·Ö×Ó»¯Ñ§ÓëÎïÀí 304·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
»·¾³¹¤³Ì 085701£¬267Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸Ö£ÖÝ´óѧ£¬080500ѧ˶£¬×Ü·Ö317·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ5È˻ظ´
ÄϾ©´óѧ»¯Ñ§µ÷¼Á
ÒѾÓÐ8È˻ظ´
37Â¥2009-09-23 14:00:44
8Â¥2009-08-16 09:15:24
11Â¥2009-08-16 10:13:14
14Â¥2009-08-16 14:05:13
¼òµ¥»Ø¸´
tjegg3Â¥
2009-08-15 20:14
»Ø¸´

















»Ø¸´´ËÂ¥